Medtronic (MDT) Liabilities from Discontinued Operations (2017)
Medtronic (MDT) reported Liabilities from Discontinued Operations of 59000000.0 for Q3 2017, up 73.53% sequentially from 34000000.0 in Q2 2017.
Medtronic (MDT) Liabilities from Discontinued Operations (2017) Analysis & Trends
Medtronic (MDT) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 59000000.0 in Q3 2017.
- For the quarter ending Q3 2017, Liabilities from Discontinued Operations changed N/A year-over-year to 59000000.0; the trailing twelve-month figure through Jul 2017 stood at 59000000.0 (changed N/A YoY), and the FY2017 full-year result was 34000000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations climbed to 59000000.0 in Q3 2017, from 34000000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 59000000.0 in Q3 2017 to a low of 34000000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 28, 2017 | 59.00 Mn |
| Jul 28, 2017 | 59.00 Mn |
| Apr 28, 2017 | 34.00 Mn |
| Apr 28, 2017 | 34.00 Mn |